Makoto Osabe

579 total citations
15 papers, 480 citations indexed

About

Makoto Osabe is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Makoto Osabe has authored 15 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Makoto Osabe's work include Pharmacogenetics and Drug Metabolism (7 papers), Estrogen and related hormone effects (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Makoto Osabe is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Estrogen and related hormone effects (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Makoto Osabe collaborates with scholars based in Japan, United States and Egypt. Makoto Osabe's co-authors include Masahiko Negishi, Masao Miwa, Junko Sugatani, Akira Ikari, Kasumi Yamakawa, L. Perera, Rick Moore, Tatsuya Sueyoshi, Tadashi Wada and Kaoru Inoue and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular and Cellular Biology.

In The Last Decade

Makoto Osabe

15 papers receiving 471 citations

Peers

Makoto Osabe
Yoav Timsit United States
Michel Kaufmann Switzerland
Timothy Moeller United States
Anja Rode United Kingdom
Makoto Osabe
Citations per year, relative to Makoto Osabe Makoto Osabe (= 1×) peers Marie José Vilarem

Countries citing papers authored by Makoto Osabe

Since Specialization
Citations

This map shows the geographic impact of Makoto Osabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Osabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Osabe more than expected).

Fields of papers citing papers by Makoto Osabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Osabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Osabe. The network helps show where Makoto Osabe may publish in the future.

Co-authorship network of co-authors of Makoto Osabe

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Osabe. A scholar is included among the top collaborators of Makoto Osabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Osabe. Makoto Osabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Uramaru, Naoto, et al.. (2023). Differential expression of Cytochrome P450 1A2 in simple fatty liver and steatohepatitis. Fundamental Toxicological Sciences. 10(6). 265–277. 1 indexed citations
2.
Uramaru, Naoto, et al.. (2023). Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes. Molecular Medicine Reports. 27(2). 3 indexed citations
4.
Shizu, Ryota, Makoto Osabe, L. Perera, et al.. (2017). Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation. Molecular and Cellular Biology. 37(10). 33 indexed citations
5.
Osabe, Makoto, Masahiro Tohkin, & N. Hirayama. (2016). <i>In silico</i> Analysis of Interactions between HLA-B*58:01 and Allopurinol-related Compounds. 16(0). 1–4. 5 indexed citations
6.
Narita, Tomoko, Masaki Ri, Shiori Kinoshita, et al.. (2016). Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma. Blood. 128(22). 4408–4408. 1 indexed citations
7.
9.
Mutoh, Shingo, Makoto Osabe, Kaoru Inoue, et al.. (2009). Dephosphorylation of Threonine 38 Is Required for Nuclear Translocation and Activation of Human Xenobiotic Receptor CAR (NR1I3). Journal of Biological Chemistry. 284(50). 34785–34792. 110 indexed citations
10.
Osabe, Makoto, et al.. (2009). Up‐regulation of CAR expression through Elk‐1 in HepG2 and SW480 cells by serum starvation stress. FEBS Letters. 583(5). 885–889. 12 indexed citations
11.
Osabe, Makoto, Junko Sugatani, Yasuhiro Yamazaki, et al.. (2008). Expression of CAR in SW480 and HepG2 cells during G1 is associated with cell proliferation. Biochemical and Biophysical Research Communications. 369(4). 1027–1033. 18 indexed citations
12.
Sugatani, Junko, Makoto Osabe, Kasumi Yamakawa, et al.. (2008). Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter. Naunyn-Schmiedeberg s Archives of Pharmacology. 377(4-6). 597–605. 44 indexed citations
13.
Sugatani, Junko, Makoto Osabe, Tadashi Wada, et al.. (2008). Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet. European Journal of Nutrition. 47(4). 192–200. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026